References
- M. K. Franchini, Particle Engineering, in Encyclopedia of Pharmaceutical Technology (Ed. J. Swarbrick), 3rd ed., Taylor & Francis, New York 2006, DOI: 10.1081/E-EPT-120030638.
- J. C. Chaumeil, Micronization: A method of improving the bioavailability of poorly soluble drugs, Methods Find. Exp. Clin. Pharmacol. 20 (1998) 211-215.
- J. C. Feeley, P. York, B. S. Sumby and H. Dicks, Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronization, Int. J. Pharm. 172 (1998) 89-96; DOI: 10.1016/S0378-5173(98)00179-3.
- M. M. de Villiers, Influence of cohesive properties of micronized drug powders on particle size analysis, J. Pharm. Biom. Anal. 13 (1995) 191-198; DOI: 10.1016/0731-7085(95)01274-O.
- A. K. Tiwary, Crystal Habit Changes and Dosage Form Performance, in Encyclopedia of Pharmaceutical Technology (Ed. J. Swarbrick), 3rd ed., Taylor & Francis, New York 2006, pp. 820-833; DOI: 10.1081/E-EPT-120019306.
- D. Kaul, N. T. Nguyen and S. Venkataram, Crystal habit modifications and altered tabletting characteristics, Int. J. Pharm. 88 (1992) 345-350; DOI: 10.1016/0378-5173(92)90333-W.
- H. A. Garekani, F. Sadeghi, A. Badiee, S. A. Mostafa and A. R. Rajabi-Siahboomi, Crystal habit modifications of ibuprofen and their physicochemical characteristics, Drug Dev. Ind. Pharm. 27 (2001) 803-809; DOI: 10.1081/DDC-100107242.
- N. Rasenack and B W. Müller, Ibuprofen crystals with optimized properties, Int. J. Pharm. 245 (2002) 9-24; DOI: 10.1016/S0378-5173(02)00294-6.
- K. R. Morris, U. J. Griesser, C. J. Eckhardt and J. G. Stowell, Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes, Adv. Drug Del. Rev. 48 (2001) 91-114; DOI: 10.1016/S0169-409X(01)00100-4.
- Y. Kawashima and C. E. Capes, An experimental study of the kinetics of spherical agglomeration in a stirred vessel, Powder Technol. 10 (1974) 85-92; DOI: 10.1016/0032-5910(74)85036-9.
- Y. Kawashima, Development of spherical crystallization technique and its application to pharmaceutical systems, Arch. Pharm. Res. 7 (1984) 145-151; DOI: 10.1007/BF02856629.
- N. Rodriguez-Hornedo, R. C. Kelly, B. D. Sinclair and J. M. Miller, Crystallization: General Principles and Significance on Product Development, in Encyclopedia of Pharmaceutical Technology (Ed. J. Swarbrick), 3rd ed., Taylor & Francis Group, New York 2006, pp. 834-857; DOI: 10.1081/E-EPT-120041347.
- A. S. Myerson and R. Ginde, Crystals, Crystal Growth, and Nucleation, in Handbook of Industrial Crystallization (Ed. A. S. Myerson), 2nd ed., Butterworth-Heinemann, Woburn 2001, pp. 33-65; DOI: 10.1016/B978-075067012-8/50004-5.
- J. W. Mullin, Crystal Growth, in Crystallization (Ed. J. W. Mullin), 4th ed., Butterworth-Heinemann, Woburn 2001, pp. 216-288; DOI: 10.1016/B978-075064833-2/50008-5.
- R. F. Sekerka, Theory of Crystal Growth Morphology, in Crystal Growth: From Fundamentals to Technology (Eds. G. Müller, J. Métois and P. Rudolph), Elsevier, Amsterdam 2004, pp. 55-93; DOI: 10.1016/B978-044451386-1/50005-2.
- Y. Kawashima, M. Okumura and H. Takenaka, The effects of temperature on the spherical crystallization of salicylic acid, Powder Technol. 39 (1984) 41-47; DOI: 10.1016/0032-5910(84)85018-4.
- H. Göczo, P. Szabó-Révész, B. Farkas, M. Hasznos-Nezdei, S. F. Serwanis, A. K. Pintye-Hódi, P. Kása, Jr., I. Eros, I. Antal and S. Marto, Development of spherical crystals of acetylsalicylic acid for direct tablet-making, Chem. Pharm. Bull. 48 (2000) 1877-1881.
- A. F. Blandin, D. Mangin, A. Rivoire, J. P. Klein and J. M. Bossoutrot, Agglomeration in suspension of salicylic acid fine particles: influences of some process parameters on kinetics and agglomerate final size, Powder Technol. 130 (2003) 316-323; DOI: 10.1016/S0032-5910(02)00210-3.
- Y. Kawashima, K. Furukawa and H. Takenaka, The physicochemical parameters determining the size of agglomerate prepared by the wet spherical agglomeration technique, Powder Technol. 30 (1981) 211-216; DOI: 10.1016/0032-5910(81)80014-9.
- A. S. Bos and F. J. Zuiderweg, Kinetics of continuous agglomeration in suspension, Powder Technol. 44 (1985) 43-51; DOI: 10.1016/0032-5910(85)85019-1.
- Z. Sadowski, Selective spherical agglomeration of fine salt-type mineral particles in aqueous solution, Colloids and Surf. A: Physicochem. Eng. Aspects 96 (1995) 277-285; DOI: 10.1016/0927-7757(94)03042-X.
- C. Skarvelakis and G. Antonini, Kinetics of agglomerate growth in a continuous coal-oil purification process, Powder Technol. 85 (1995) 135-141; DOI: 10.1016/0892-6875(89)90038-1.
- B. A. Snyder and J. C. Berg, Oil-assisted agglomeration for toner deinking: Population balance model and experiments, AlChE J. 43 (1997) 1480-1487; DOI: 10.1002/aic.690430611.
- J. S. Laskowski and Z. Yu, Oil agglomeration and its effect on beneficiation and filtration of low-rank/oxidized coals, Int. J. Min. Proc. 58 (2000) 237-252; DOI: 10.1016/S0301-7516(99)90040-6.
- C. I. House and C. J. Veal, Selective recovery of chalcopyrite by spherical agglomeration, Min. Eng. 2 (1989) 171-184; DOI: 10.1016/0892-6875(89)90038-1.
- A. Y. Huang and J. C. Berg, Gelation of liquid bridges in spherical agglomeration, Colloids and Surf. A: Physicochem. Eng. Aspects 215 (2003) 241-252; DOI: 10.1016/S0927-7757(02)00488-0.
- S. Mahanty, J. Sruti, C. Niranjan Patra and M. E. Bhanoji Rao, Particle design of drugs by spherical crystallization techniques, Int. J. Pharm. Sci. Nanotech. 3 (2010) 912-918.
- J. Thati and Å. C. Rasmuson, On the mechanisms of formation of spherical agglomerates, Eur. J. Pharm. Sci. 42 (2011) 365-379; DOI: 10.1016/j.ejps.2011.01.001.
- Y. Kawashima, F. Cui, H. Takeuchi, T. Niwa, T. Hino and K. Kiuchi, Parameters determining the agglomeration behaviour and the micromeritic properties of spherically agglomerated crystals prepared by the spherical crystallization technique with miscible solvent systems, Int. J. Pharm. 119 (1995) 139-147; DOI: 10.1016/0378-5173(94)00380-N.
- J. Katta and A. C. Rasmuson, Spherical crystallization of benzoic acid, Int. J. Pharm. 348 (2008) 61-69; DOI: 10.1016/j.ijpharm.2007.07.006.
- H. Zhang, Y. Chen, J. Wang and J. Gong, Investigation on the spherical crystallization process of cefotaxime sodium, Ind. Eng. Chem. Res. 49 (2010) 1402-1411; DOI: 10.1021/ie901001c.
- D. Amaro-González and B. Biscans, Spherical agglomeration during crystallization of an active pharmaceutical ingredient, Powder Technol. 128 (2002) 188-194; DOI: 10.1016/S0032-5910(02)00196-1.
- A. H. L. Chow and M. W. M. Leung, A study of the mechanisms of wet spherical agglomeration of pharmaceutical powders, Drug Dev. Ind. Pharm. 22 (1996) 357-371; DOI: 10.3109/03639049609042001.
- M. Maghsoodi, Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique, Pharm. Dev. Technol. 16 (2011)474-482; DOI: 10.3109/10837450.2010.492218.
- Y. Kawashima, T. Niwa, T. Handa, H. Takeuchi, T. Iwamoto and K. Itoh, Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method, J. Pharm. Sci. 78 (1989) 68-72; DOI: 10.1002/jps.2600780118.
- A. Sano, T. Kuriki, Y. Kawashima, T. Hino and T. Niwa, Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method, Chem. Pharm. Bull. 38 (1990) 733-739.
- K. Morishima, Y. Kawashima, H. Takeuchi, T. Niwa and T. Hino, Micromeritic characteristics and agglomeration mechanisms in the spherical crystallization of bucillamine by the spherical agglomeration and the emulsion solvent diffusion methods, Powder Technol. 76 (1993) 57-64; DOI: 10.1016/0032-5910(93)80041-8.
- F. Espitalier, B. Biscans and C. Laguérie, Particle design Part A: Nucleation kinetics of ketoprofen, Chem. Eng. J. 68 (1997) 95-102; DOI: 10.1016/S1385-8947(97)00089-2.
- Y. Kawashima, M. Imai, H. Takeuchi, H. Yamamoto, K. Kamiya and T. Hino, Improved flowability and compactibility of spherically agglomerated crystals of ascorbic acid for direct tabletting designed by spherical crystallization process, Powder Technol. 130 (2003) 283-289; DOI: 10.1016/S0032-5910(02)00206-1.
- M. Nocent, L. Bertocchi, F. Espitalier, M. Baron and G. Couarraze, Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method, J. Pharm. Sci. 90 (2001) 1620-1627; DOI: 10.1002/jps.1112.
- F. Espitalier, B. Biscans and C. Laguérie, Particle design Part B: batch quasi-emulsion process and mechanism of grain formation of ketoprofen, Chem. Eng. J. 68 (1997) 103-114; DOI: 10.1016/S1385-8947(97)00057-0.
- Z. Zhang, Z. Shen, J. Wang, H. X. Zhang, H. Zhao, J. F. Chen and J. Yun, Micronization of silybin by the emulsion solvent diffusion method, Int. J. Pharm. 376 (2009) 116-122; DOI: 10.1016/j.ijpharm.2009.04.028.
- M. Maghsoodi and M. Esfehani, Preparation of microparticles of naproxen with Eudragit RS and Talc by spherical crystallization technique, Pharm. Dev. Technol. 14 (2009) 442-450; DOI: 10.1080/10837450902748404.
- M. Ueda, Y. Nakamura, H. Makita, Y. Imasato and Y. Kawashima, Particle design of enoxacinby spherical crystallization technique. I. Principle of ammonia diffusion system (ADS), Chem. Pharm. Bull. 38 (1990) 2537-2541.
- S. Bhadra, M. Kumar, S. Jain, S. Agrawal and G. P. Agrawal, Spherical crystallization of mefenamic acid, Pharm. Technol. (2004) 66-76.
- H. G. Puechagut, J. Bianchotti and C. A. Chiale, Preparation of norfloxacin spherical agglomerates using the ammonia diffusion system, J. Pharm. Sci. 87 (1998) 519-523; DOI: 10.1021/js960463w.
- S. S, Kadam, K. R. Mahadik and A. R. Paradkar, A Process for Making Agglomerates for Use as Or in a Drug Delivery System, Indian Patent 183036, 14 Feb 1997.
- A. Pawar, A. Paradkar, S. Kadam and K. Mahadik, Agglomeration of ibuprofen with talc by novel crystallo-co-agglomeration technique, AAPS Pharm. Sci. Tech. 5 (2004) Article 55; DOI: 10.1208/pt050455.
- M. Maghsoodi, O. Taghizadeh, G. P. Martin and A. Nokhodchi, Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique, Int. J. Pharm. 351 (2008) 45-54; DOI: 10.1016/j.ijpharm.2007.09.033.
- A. Pawar, A. Paradkar, S. Kadam and K. Mahadik, Crystallo-co-agglomeration: A novel technique to obtain ibuprofen-paracetamol agglomerates, AAPS Pharm. Sci. Tech. 5 (2004) Article 44; DOI: 10.1208/pt050344.
- A. Pawar, A. R. Paradkar, S. S. Kadam and K. R. Mahadik, Effect of polymers on crystallo-co-agglomeration of ibuprofen-paracetamol: Factorial design, Ind. J. Pharm. Sci. 69 (2007) 658-664; DOI: 10.4103/0250-474X.38471.
- P. Szabó-Révész, H. Göczo, K. Pintye-Hodi, P. Kása, Jr., I. Erõs, M. Hasznos-Nezdei and B. Farkas, Development of spherical crystal agglomerates of an aspartic acid salt for direct tablet making, Powder Technol. 114 (2001) 118-124; DOI: 10.1016/S0032-5910(00)00272-2.
- M. Maghsoodi, D. Hassan-Zadeh, M. Barzegar-Jalali, A. Nokhodchi and G. Martin, Improved compaction and packing properties of naproxen agglomerated crystals obtained by spherical crystallization technique, Drug Dev. Ind. Pharm. 33 (2007) 1216-1224; DOI: 10.1080/03639040701377730.
- M. Maghsoodi and A. S. Tajalli Bakhsh, Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization, Pharm. Dev. Technol. 16 (2011) 243-249; DOI: 10.3109/10837451003610837.
- A. Nokhodchi and M. Maghsoodi, Preparation of spherical crystal agglomerates of naproxen containing disintegrant for direct tablet making by spherical crystallization technique, AAPS PharmSciTech. 9 (2008) 54-59; DOI: 10.1208/s12249-007-9019-3.
- A. N. Usha, S. Mutalik, M. S. Reddy and A. K. Ranjith, Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates, Eur. J. Pharm. Biopharm. 70 (2008) 674-683; DOI: 10.1016/j.ejpb.2008.06.010.
- S. Kumar, G. Chawla and A. K. Bansal, Spherical crystallization of mebendazole to improve processability, Pharm. Dev. Technol. 13 (2008) 559-568; DOI: 10.1080/10837450802310180.
- C. L. Viswanathan, S. K. Kulkarni and D. R. Kolwankar, Spherical agglomeration of mefenamic acid and nabumetone to improve micromeritics and solubility: A technical note, AAPS Pharm SciTech 7 (2006) E122-E125, DOI: 10.1208/pt070248.
- V. R. Gupta, S. Mutalik, M. M. Patel and G. K. Jani, Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties, Acta Pharm. 57 (2007) 173-184; DOI: 10.2478/v10007-007-0014-8.
- A. R. Paradkar, A. P. Pawar, J. K. Chordiya, V. B. Patil and A. R. Ketkar, Spherical crystallization of celecoxib, Drug Dev. Ind. Pharm. 28 (2002) 1213-1220; DOI: 10.1081/DDC-120015354.
- P. Di Martino, C. Barthélémy, F. Piva, E. Joiris, G. F. Palmieri and S. Martelli, Improved dissolution behavior of fenbufen by spherical crystallization, Drug Dev. Ind. Pharm. 25 (1999) 1073-1081; DOI: 10.1081/DDC-100102272.
- M. Maghsoodi and F. Sadeghpoor, Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique, Drug Dev. Ind. Pharm. 36 (2010) 917-925; DOI: 10.3109/03639040903585127.
- F. Cui, M. Yang, Y. Jiang, D. Cun, W. Lina, Y. Fana and Y. Kawashimab, Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method, J. Control. Release 91 (2003) 375-384; DOI: 10.1016/S0168-3659(03)00275-X.
- M. Yang, F. Cui, B. You, Y. Fan, L. Wang, P. Yue and H. Yang, Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method, Int. J. Pharm. 259 (2003) 103-113; DOI: 10.1016/S0378-5173(03)00209-6.
- J. Varshosaz, N. Tavakoli and F. A. Salamat, Enhanced dissolution rate of simvastatin using spherical crystallization technique, Pharm. Dev. Technol. 16 (2011) 529-535; DOI: 10.3109/10837450.2010.502175.